Join
Live feed
·
INSIDERFilingvia Quantisnow
AVEO Pharmaceuticals Inc. logo

SEC Form 4: Ferraresso Michael returned $245,175 worth of shares to the company (16,345 units at $15.00), closing all direct ownership in the company to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.
AVEO· AVEO Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVEO (AVEO Pharmaceuticals Inc.) and more on Quantisnow.